Bank of New York Mellon’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Hold |
26,749
| – | – | ﹤0.01% | 3971 |
|
|
2025
Q1 | $232K | Hold |
26,749
| – | – | ﹤0.01% | 3802 |
|
|
2024
Q4 | $229K | Hold |
26,749
| – | – | ﹤0.01% | 3879 |
|
|
2024
Q3 | $130K | Hold |
26,749
| – | – | ﹤0.01% | 3969 |
|
|
2024
Q2 | $138K | Hold |
26,749
| – | – | ﹤0.01% | 3992 |
|
|
2024
Q1 | $131K | Sell |
26,749
-4,026
| -13% | -$19.7K | ﹤0.01% | 3995 |
|
|
2023
Q4 | $173K | Hold |
30,775
| – | – | ﹤0.01% | 3984 |
|
|
2023
Q3 | $191K | Hold |
30,775
| – | – | ﹤0.01% | 3962 |
|
|
2023
Q2 | $196K | Hold |
30,775
| – | – | ﹤0.01% | 3971 |
|
|
2023
Q1 | $124K | Hold |
30,775
| – | – | ﹤0.01% | 4037 |
|
|
2022
Q4 | $139K | Hold |
30,775
| – | – | ﹤0.01% | 4070 |
|
|
2022
Q3 | $231K | Hold |
30,775
| – | – | ﹤0.01% | 3954 |
|
|
2022
Q2 | $246K | Hold |
30,775
| – | – | ﹤0.01% | 3974 |
|
|
2022
Q1 | $250K | Hold |
30,775
| – | – | ﹤0.01% | 4115 |
|
|
2021
Q4 | $257K | Hold |
30,775
| – | – | ﹤0.01% | 4157 |
|
|
2021
Q3 | $314K | Sell |
30,775
-21,050
| -41% | -$215K | ﹤0.01% | 4013 |
|
|
2021
Q2 | $533K | Sell |
51,825
-16,424
| -24% | -$169K | ﹤0.01% | 3737 |
|
|
2021
Q1 | $772K | Sell |
68,249
-490
| -0.7% | -$5.54K | ﹤0.01% | 3472 |
|
|
2020
Q4 | $741K | Sell |
68,739
-754
| -1% | -$8.13K | ﹤0.01% | 3419 |
|
|
2020
Q3 | $642K | Hold |
69,493
| – | – | ﹤0.01% | 3365 |
|
|
2020
Q2 | $664K | Buy |
69,493
+17,178
| +33% | +$164K | ﹤0.01% | 3324 |
|
|
2020
Q1 | $387K | Hold |
52,315
| – | – | ﹤0.01% | 3489 |
|
|
2019
Q4 | $436K | Hold |
52,315
| – | – | ﹤0.01% | 3648 |
|
|
2019
Q3 | $295K | Hold |
52,315
| – | – | ﹤0.01% | 3777 |
|
|
2019
Q2 | $409K | Hold |
52,315
| – | – | ﹤0.01% | 3692 |
|
|
2019
Q1 | $512K | Sell |
52,315
-164
| -0.3% | -$1.61K | ﹤0.01% | 3535 |
|
|
2018
Q4 | $409K | Buy |
+52,479
| New | +$409K | ﹤0.01% | 3583 |
|